🔎 Trials Near Me

Home › Arrhythmia › Ohio

Arrhythmia clinical trials in Ohio

7 studies for Arrhythmia are looking for participants at sites in Ohio.

Cities in Ohio

Safety and Effectiveness of the Sphere-9â„¢ Catheter and Afferaâ„¢ Ablation System for the Treatment of Ventricular Tachycardia (Sphere VT)

  • The Ohio State University Wexner Medical Center, Columbus
Recruiting
Ages 18 to 85 · All sexes · Updated Sep 29, 2026 · NCT07585968

Biospecimen Repository for Cardiac Arrhythmias at the Cleveland Clinic

  • Cleveland Clinic Foundation, Cleveland
RecruitingObservational studyHealthy volunteers welcome
Ages 18 and older · All sexes · Updated Sep 14, 2026 · NCT00921986

Surveillance Trial of the Apple Watch in Reliable Burden Assessment in Unseen Recurrence of Surgically Treated AF

  • Cleveland Clinic, Cleveland
RecruitingObservational study
Ages 22 and older · All sexes · Updated Sep 8, 2026 · NCT07122947

Safety and Performance Assessment of the Sphere-9â„¢ Catheter and Afferaâ„¢ Ablation System for the Treatment of Ventricular Tachycardia (Sphere-9 VT EFS)

  • Cleveland Clinic Foundation, Cleveland
Recruiting
Ages 18 to 85 · All sexes · Updated Sep 3, 2026 · NCT06703489

Pharmacokinetics, Pharmacodynamics, and Safety Profile of Understudied Drugs Administered to Children Per Standard of Care (POPS)

  • Cincinnati Childrens Hospital Medical Center, Cincinnati
RecruitingObservational studyHealthy volunteers welcome
Ages 0 to 20 · All sexes · Updated Aug 21, 2026 · NCT04278404

Product Performance Report: Evaluate Long-term Reliability & Performance of Medtronic Marketed Cardiac Therapy Products

  • Cincinnati
  • Cleveland
  • Columbus
  • and 1 more
RecruitingObservational study
All ages · All sexes · Updated Aug 20, 2026 · NCT00271180

The PIVATAL Study -Study of Ventricular Arrhythmia (VTA) Ablation in Left Ventricular Assist Device (LVAD) Patients

  • Cleveland Clinic, Cleveland
RecruitingPhase 4
Ages 18 and older · All sexes · Updated Jul 14, 2026 · NCT05034432

From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.